165 related articles for article (PubMed ID: 37651069)
1. Disparities in US Lung Cancer Clinical Trial Enrollment.
Kilic S; Zhao J; Okut H; Jani CT; Radwan A; Dudipala H; Burns L; Tapan U
J Racial Ethn Health Disparities; 2023 Aug; ():. PubMed ID: 37651069
[TBL] [Abstract][Full Text] [Related]
2. Racial and Ethnic Disparities in Clinical Trial Enrollment Among Women With Gynecologic Cancer.
Khadraoui W; Meade CE; Backes FJ; Felix AS
JAMA Netw Open; 2023 Dec; 6(12):e2346494. PubMed ID: 38060227
[TBL] [Abstract][Full Text] [Related]
3. Participation in cancer clinical trials: race-, sex-, and age-based disparities.
Murthy VH; Krumholz HM; Gross CP
JAMA; 2004 Jun; 291(22):2720-6. PubMed ID: 15187053
[TBL] [Abstract][Full Text] [Related]
4. Racial and Ethnic Disparities in Primary Open-Angle Glaucoma Clinical Trials: A Systematic Review and Meta-analysis.
Allison K; Patel DG; Greene L
JAMA Netw Open; 2021 May; 4(5):e218348. PubMed ID: 34003274
[TBL] [Abstract][Full Text] [Related]
5. Race and Ethnicity Reporting and Representation in Pediatric Clinical Trials.
Brewster RCL; Steinberg JR; Magnani CJ; Jackson J; Wong BO; Valikodath N; MacDonald J; Li A; Marsland P; Goodman SN; Schroeder A; Turner B
Pediatrics; 2023 Apr; 151(4):. PubMed ID: 36916197
[TBL] [Abstract][Full Text] [Related]
6. Racial and Ethnic Disparities Among Participants in Precision Oncology Clinical Studies.
Aldrighetti CM; Niemierko A; Van Allen E; Willers H; Kamran SC
JAMA Netw Open; 2021 Nov; 4(11):e2133205. PubMed ID: 34748007
[TBL] [Abstract][Full Text] [Related]
7. Participation of Patients From Racial and Ethnic Minority Groups in Phase 1 Early Cancer Drug Development Trials in the US, 2000-2018.
Dunlop H; Fitzpatrick E; Kurti K; Deeb S; Gillespie EF; Dover L; Yerramilli D; Gomez SL; Chino F; Tsai CJ
JAMA Netw Open; 2022 Nov; 5(11):e2239884. PubMed ID: 36326764
[TBL] [Abstract][Full Text] [Related]
8. Assessment of the Inclusion of Racial/Ethnic Minority, Female, and Older Individuals in Vaccine Clinical Trials.
Flores LE; Frontera WR; Andrasik MP; Del Rio C; Mondríguez-González A; Price SA; Krantz EM; Pergam SA; Silver JK
JAMA Netw Open; 2021 Feb; 4(2):e2037640. PubMed ID: 33606033
[TBL] [Abstract][Full Text] [Related]
9. Underrepresentation of Hispanics in clinical trials for liver cancer in the United States over the past 20 years.
Monge C; Greten TF
Cancer Med; 2023 Dec; 13(1):. PubMed ID: 38124450
[TBL] [Abstract][Full Text] [Related]
10. Disparities in Representation of Women, Older Adults, and Racial/Ethnic Minorities in Immune Checkpoint Inhibitor Trials.
Riaz IB; Islam M; Khan AM; Naqvi SAA; Siddiqi R; Khakwani KZR; Asghar N; Ikram W; Hussain SA; Singh P; Warner JL; Sonpavde GP; Odedina FT; Kehl KL; Duma N; Bryce AH
Am J Med; 2022 Aug; 135(8):984-992.e6. PubMed ID: 35483426
[TBL] [Abstract][Full Text] [Related]
11. Reporting of Participant Race and Ethnicity in Published US Pediatric Clinical Trials From 2011 to 2020.
Rees CA; Stewart AM; Mehta S; Avakame E; Jackson J; McKay J; Portillo EN; Michelson KA; Duggan CP; Fleegler EW
JAMA Pediatr; 2022 May; 176(5):e220142. PubMed ID: 35311946
[TBL] [Abstract][Full Text] [Related]
12. Enrollment of Individuals From Racial and Ethnic Minority Groups in Gynecologic Cancer Precision Oncology Trials.
Mattei LH; Robb L; Banning K; Polan RM; Cote ML
Obstet Gynecol; 2022 Oct; 140(4):654-661. PubMed ID: 36075065
[TBL] [Abstract][Full Text] [Related]
13. Enrollment Trends and Disparity Among Patients With Lung Cancer in National Clinical Trials, 1990 to 2012.
Pang HH; Wang X; Stinchcombe TE; Wong ML; Cheng P; Ganti AK; Sargent DJ; Zhang Y; Hu C; Mandrekar SJ; Redman MW; Manola JB; Schilsky RL; Cohen HJ; Bradley JD; Adjei AA; Gandara D; Ramalingam SS; Vokes EE
J Clin Oncol; 2016 Nov; 34(33):3992-3999. PubMed ID: 27646951
[TBL] [Abstract][Full Text] [Related]
14. Racial/Ethnic Disparities in Ophthalmology Clinical Trials Resulting in US Food and Drug Administration Drug Approvals From 2000 to 2020.
Berkowitz ST; Groth SL; Gangaputra S; Patel S
JAMA Ophthalmol; 2021 Jun; 139(6):629-637. PubMed ID: 33885724
[TBL] [Abstract][Full Text] [Related]
15. Participation in surgical oncology clinical trials: gender-, race/ethnicity-, and age-based disparities.
Stewart JH; Bertoni AG; Staten JL; Levine EA; Gross CP
Ann Surg Oncol; 2007 Dec; 14(12):3328-34. PubMed ID: 17682824
[TBL] [Abstract][Full Text] [Related]
16. The role of race and ethnicity in the State Children's Health Insurance Program (SCHIP) in four states: are there baseline disparities, and what do they mean for SCHIP?
Shone LP; Dick AW; Brach C; Kimminau KS; LaClair BJ; Shenkman EA; Col JF; Schaffer VA; Mulvihill F; Szilagyi PG; Klein JD; VanLandeghem K; Bronstein J
Pediatrics; 2003 Dec; 112(6 Pt 2):e521. PubMed ID: 14654674
[TBL] [Abstract][Full Text] [Related]
17. Variation in Breast Cancer Subtype Incidence and Distribution by Race/Ethnicity in the United States From 2010 to 2015.
Kong X; Liu Z; Cheng R; Sun L; Huang S; Fang Y; Wang J
JAMA Netw Open; 2020 Oct; 3(10):e2020303. PubMed ID: 33074325
[TBL] [Abstract][Full Text] [Related]
18. The impact of the globalization of cancer clinical trials on the enrollment of Black patients.
Tharakan S; Zhong X; Galsky MD
Cancer; 2021 Jul; 127(13):2294-2301. PubMed ID: 33682111
[TBL] [Abstract][Full Text] [Related]
19. Interventions to increase racial and ethnic minority accrual into cancer clinical trials: A systematic review.
Nouvini R; Parker PA; Malling CD; Godwin K; Costas-Muñiz R
Cancer; 2022 Nov; 128(21):3860-3869. PubMed ID: 36107740
[TBL] [Abstract][Full Text] [Related]
20. Race, ethnicity, and gender reporting in North American clinical trials for BCG-unresponsive non-muscle invasive bladder cancer.
Fletcher SA; Bivalacqua TJ; Brawley OW; Kates M
Urol Oncol; 2022 May; 40(5):195.e13-195.e18. PubMed ID: 34949513
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
